Cutaneous leukocytoclastic vasculitis associated with letrozole

被引：7

作者：

Digklia, Antonia

Tzika, Evangelia

Voutsadakis, Ioannis A.

机构：

[1] Centre Pluridisciplinaire d'Oncologie, BH06, Centre Hospitalier Universitaire Vaudois, Lausanne 1011

来源：

JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2014年 / 20卷 / 02期

关键词：

cutaneous vasculitis; breast cancer; skin adverse effects; letrozole; Aromatase inhibitors;

D O I：

10.1177/1078155213480535

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.

引用

页码：146 / 148

页数：3

共 9 条

[1]

Xu H.-B., Liu Y.-J., Li L., Aromatase inhibitor versus tamoxifen in postmenopausal woman with advanced breast cancer: A literature-based meta-analysis, Clin Breast Cancer, 4, pp. 246-251, (2011)

[2]

Jhaveri K., Halperin P., Shin S.J., Vahdat L., Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: Case reports and review of the literature, Breast Cancer Research and Treatment, 106, 3, pp. 315-318, (2007)

[3]

Trancart M., Cavailhes A., Balme B., Skowron F., Anastrozole-induced subacute cutaneous lupus erythematosus [3], British Journal of Dermatology, 158, 3, pp. 628-629, (2008)

[4]

Bremec T., Demsar J., Luzar B., Drug-induced pruritic micropapular eruption: Anastrozole, a commonly used aromatase inhibitor, Dermatol Online J, 15, pp. 14-14, (2009)

[5]

Santoro S., Santini M., Pepe C.A., Aromatase inhibitor-induced skin adverse reactions: Exemestane-related cutaneous vasculitis, J Eur Acad Dermatol Venereol, 25, pp. 596-598, (2011)

[6]

Chen K.-R., Carlson J.A., Clinical approach to cutaneous vasculitis, American Journal of Clinical Dermatology, 9, 2, pp. 71-92, (2008)

[7]

Shoda H., Inokuma S., Yajima N., Tanaka Y., Setoguchi K., Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment, Annals of the Rheumatic Diseases, 64, 4, pp. 651-652, (2005)

[8]

Wong M., Grossman J., Hahn B.H., Cutaneous vasculitis in breast cancer treated with chemotherapy, Clin Immunol, 129, pp. 3-9, (2008)

[9]

Van Vollenhoven R.F., Adhesion molecules, sex steroids, and the pathogenesis of vasculitis syndromes, Curr Opin Rheumatol, 7, pp. 4-10, (1995)

← 1 →